At a glance
- Originator Banyu
- Class Antibacterials; Carbapenems
- Mechanism of Action Cell wall inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Bacterial infections
Most Recent Events
- 15 Jun 2000 Preclinical development for Bacterial infections in Japan (Parenteral)
- 09 Oct 1998 New profile